Siemens to produce molecular imaging biomarkers in India

TriMed Staff | | Health Imaging | Molecular Imaging
Siemens Medical Solutions is launching its first molecular imaging biomarker production facility in Chennai, India, through its company PETNET Solutions.

The new facility will enable healthcare providers in and around Chennai to access PET technology to diagnose patients with life-threatening diseases such as cancer as well as cardiac and neuro ailments, according to Siemens.

PETNET Solutions operates a large PET radiopharmacy network with more than 44 radiopharmacies and distribution centers at multiple locations in the United States, Korea and the United Kingdom, which produce and distribute PET radiopharmaceuticals to hospitals, clinics and research facilities for PET imaging.

TriMed Staff

Related Content

Researchers receive grant worth millions to develop portable PET scanner
Why is the US still dependent on foreign medical isotope production?
Downed high-flux reactor could restart sooner than anticipated
Some nuc med departments are already feeling the strain of the isotope shortage
NorthStar opens facility to assist with development and distribution of vital radioisotopes
Lizard saliva could be key to spotting elusive pancreatic tumors

Around the web

Cardiovascular Business
New AI program delivers rapid, accurate echo video assessments

The new technology shows early potential to make a significant impact on imaging workflows and patient care. 

Radiology Business
Key Medicare reimbursement and No Surprises Act updates from RSNA 2024

Richard Heller III, MD, RSNA board member and senior VP of policy at Radiology Partners, offers an overview of policies in Congress that are directly impacting imaging.
 

Cardiovascular Business
Philips, Mayo Clinic using AI to improve cardiac MRI technology

The two companies aim to improve patient access to high-quality MRI scans by combining their artificial intelligence capabilities.